In severe asthma, especially in patients resistant to glucocorticoid therapy, the M1 macrophage phenotype predominates, producing numerous pro-inflammatory mediators, such as TNF-α, IL-1β and NO, which aggravate lung injury and accelerate airway remodeling [59]. This evidence concerns the gene IL1B and asthma.